The ebola virus matrix protein VP40 selectively induces vesiculation from phosphatidylserine-enriched membranes

Journal of Biological Chemistry

Volumn 289, Issue 48, 2014, Pages 33590-33597

  Soni, Smita P ^a   Stahelin, Robert V ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; DISEASES; MAMMALS; PHOSPHOLIPIDS; PROTEINS;

GIANT UNILAMELLAR VESICLES; LIPID COMPOSITION; MAMMALIAN CELLS; PHOSPHATIDYLSERINE; PHOSPHOINOSITIDES; VIRULENT PATHOGENS; VIRUS PARTICLES; VIRUS-LIKE PARTICLES;

VIRUSES;

CHOLESTEROL; PHOSPHATIDYLSERINE; PROTEIN VP40; ARTIFICIAL MEMBRANE; MATRIX PROTEIN; VP40 PROTEIN, VIRUS;

ARTICLE; CONTROLLED STUDY; EBOLA VIRUS; GIANT UNILAMELLAR VESICLE; LIPID COMPOSITION; LIPID MEMBRANE; LIPID VESICLE; NONHUMAN; PROTEIN LIPID INTERACTION; VIRUS RELEASE; VIRUS REPLICATION; ARTIFICIAL MEMBRANE; BIOLOGICAL MODEL; CHEMISTRY; EBOLAVIRUS; METABOLISM; PHYSIOLOGY;

EBOLA VIRUS;

EBOLAVIRUS; MEMBRANES, ARTIFICIAL; MODELS, BIOLOGICAL; PHOSPHATIDYLSERINES; VIRAL MATRIX PROTEINS; VIRUS RELEASE;

EID: 84912096164     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.586396     Document Type: Article

References (51)

1. Ksiazek, T. G. (1999) Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179, S177-S187
2. Johnson, K. M., Lange, J. V., Webb, P. A., and Murphy, F. A. (1977) Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1, 569-571
3. Feldmann, H. (2014) Ebola: a growing threat? N. Engl. J. Med. 371, 1375-1378
4. Farrar, J. J., and Piot, P. (2014) The Ebola emergency: immediate action, ongoing strategy. N. Engl. J. Med. 371, 1481-1495
5. Blaney, J. E., Marzi, A., Willet, M., Papaneri, A. B., Wirblich, C., Feldmann, F., Holbrook, M., Jahrling, P., Feldmann, H., and Schnell, M. J. (2013) Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with Rabies virus based bivalent vaccine. PLoS Pathog. 9, e1003389
6. Johansen, L. M., Brannan, J. M., Delos, S. E., Shoemaker, C. J., Stossel, A., Lear, C., Hoffstrom, B. G., DeWald, L. E., Schornberg, K. L., Scully, C., Lehár, J., Hensley, L. E., White, J. M., and Olinger, G. G. (2013) FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci. Transl. Med. 5, 190ra179
7. Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J. B., Fausther-Bovendo, H., Wei, H., Aviles, J., Hiatt, E., Johnson, A., Morton, J., Swope, K., Bohorov, O., Bohorova, N., Goodman, C., Kim, D., Pauly, M. H., Velasco, J., Pettitt, J., Olinger, G. G., Whaley, K., Xu, B., Strong, J. E., Zeitlin, L., and Kobinger, G. P. (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47-53
8. Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R., and Saphire, E. O. (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177-182
9. Miller, E. H., Obernosterer, G., Raaben, M., Herbert, A. S., Deffieu, M. S., Krishnan, A., Ndungo, E., Sandesara, R. G., Carette, J. E., Kuehne, A. I., Ruthel, G., Pfeffer, S. R., Dye, J. M., Whelan, S. P., Brummelkamp, T. R., and Chandran, K. (2012) Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 31, 1947-1960
10. Côté, M., Misasi, J., Ren, T., Bruchez, A., Lee, K., Filone, C. M., Hensley, L., Li, Q., Ory, D., Chandran, K., and Cunningham, J. (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477, 344-348
11. Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., Dal Cin, P., Dye, J. M., Whelan, S. P., Chandran, K., and Brummelkamp, T. R. (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340-343
12. Jasenosky, L. D., Neumann, G., Lukashevich, I., and Kawaoka, Y. (2001) Ebola virus VP40-induced particle formation and association with the lipid bilayer. J. Virol. 75, 5205-5214
13. McCarthy, S. E., Johnson, R. F., Zhang, Y. A., Sunyer, J. O., and Harty, R. N. (2007) Role for amino acids 212KLR214 of Ebola virus VP40 in assembly and budding. J. Virol. 81, 11452-11460
14. Bornholdt, Z. A., Noda, T., Abelson, D. M., Halfmann, P., Wood, M. R., Kawaoka, Y., and Saphire, E. O. (2013) Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle. Cell 154, 763-774
15. Olejnik, J., Ryabchikova, E., Corley, R. B., and Mühlberger, E. (2011) Intracellular events and cell fate in filovirus infection. Viruses 3, 1501-1531
16. Harty, R. N. (2009) No exit: targeting the budding process to inhibit filovirus replication. Antiviral Res. 81, 189-197
17. Adu-Gyamfi, E., Digman, M. A., Gratton, E., and Stahelin, R. V. (2012) Investigation of Ebola VP40 assembly and oligomerization in live cells using number and brightness analysis. Biophys. J. 102, 2517-2525
18. Licata, J. M., Johnson, R. F., Han, Z., and Harty, R. N. (2004) Contribution of Ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. J. Virol. 78, 7344-7351
19. Soni, S. P., Adu-Gyamfi, E., Yong, S. S., Jee, C. S., and Stahelin, R. V. (2013) The Ebola virus matrix protein deeply penetrates the plasma membrane: an important step in viral egress. Biophys. J. 104, 1940-1949
20. Adu-Gyamfi, E., Soni, S. P., Xue, Y., Digman, M. A., Gratton, E., and Stahelin, R. V. (2013) The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress. J. Biol. Chem. 288, 5779-5789
21. Ruigrok, R. W., Schoehn, G., Dessen, A., Forest, E., Volchkov, V., Dolnik, O., Klenk, H. D., and Weissenhorn, W. (2000) Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus. J. Mol. Biol. 300, 103-112
22. Stahelin, R. V. (2014) Membrane binding and bending in Ebola VP40 assembly and egress. Front. Microbiol. 5, 300
23. Martin-Serrano, J., Zang, T., and Bieniasz, P. D. (2001) HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7, 1313-1319
24. Timmins, J., Schoehn, G., Ricard-Blum, S., Scianimanico, S., Vernet, T., Ruigrok, R. W., and Weissenhorn, W. (2003) Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J. Mol. Biol. 326, 493-502
25. Henne, W. M., Buchkovich, N. J., and Emr, S. D. (2011) The ESCRT pathway. Dev. Cell 21, 77-91
26. Neumann, G., Ebihara, H., Takada, A., Noda, T., Kobasa, D., Jasenosky, L. D., Watanabe, S., Kim, J. H., Feldmann, H., and Kawaoka, Y. (2005) Ebola virus VP40 late domains are not essential for viral replication in cell culture. J. Virol. 79, 10300-10307
27. Wollert, T., Wunder, C., Lippincott-Schwartz, J., and Hurley, J. H. (2009) Membrane scission by the ESCRT-III complex. Nature 458, 172-177
28. Solon, J., Gareil, O., Bassereau, P., and Gaudin, Y. (2005) Membrane deformations induced by the matrix protein of vesicular stomatitis virus in a minimal system. J. Gen. Virol. 86, 3357-3363
29. Shnyrova, A. V., Ayllon, J., Mikhalyov, I. I., Villar, E., Zimmerberg, J., and Frolov, V. A. (2007) Vesicle formation by self-assembly of membranebound matrix proteins into a fluidlike budding domain. J. Cell Biol. 179, 627-633
30. Saarikangas, J., Zhao, H., Pykäläinen, A., Laurinmäki, P., Mattila, P. K., Kinnunen, P. K., Butcher, S. J., and Lappalainen, P. (2009) Molecular mechanisms of membrane deformation by I-BAR domain proteins. Curr. Biol. 19, 95-107
31. Yeung, T., Gilbert, G. E., Shi, J., Silvius, J., Kapus, A., and Grinstein, S. (2008) Membrane phosphatidylserine regulates surface charge and protein localization. Science 319, 210-213
32. Mattila, P. K., Pykäläinen, A., Saarikangas, J., Paavilainen, V. O., Vihinen, H., Jokitalo, E., and Lappalainen, P. (2007) Missing-in-metastasis and IRSp53 deform PI (4,5)P2-rich membranes by an inverse BAR domain-like mechanism. J. Cell Biol. 176, 953-964
33. 2 induces membrane curvature changes. J. Lipid Res. 53, 2656-2666
34. He, J., Vora, M., Haney, R. M., Filonov, G. S., Musselman, C. A., Burd, C. G., Kutateladze, A. G., Verkhusha, V. V., Stahelin, R. V., and Kutateladze, T. G. (2009) Membrane insertion of the FYVE domain is modulated by pH. Proteins 76, 852-860
35. Stahelin, R. V. (2014) Could the Ebola virus matrix protein VP40 be a drug target? Expert Opin. Ther. Targets 18, 115-120
36. Kay, J. G., Koivusalo, M., Ma, X., Wohland, T., and Grinstein, S. (2012) Phosphatidylserine dynamics in cellular membranes. Mol. Biol. Cell 23, 2198-2212
37. Stachowiak, J. C., Schmid, E. M., Ryan, C. J., Ann, H. S., Sasaki, D. Y., Sherman, M. B., Geissler, P. L., Fletcher, D. A., and Hayden, C. C. (2012) Membrane bending by protein-protein crowding. Nat. Cell Biol. 14, 944-949
38. Bharat, T. A., Noda, T., Riches, J. D., Kraehling, V., Kolesnikova, L., Becker, S., Kawaoka, Y., and Briggs, J. A. (2012) Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc. Natl. Acad. Sci. U.S.A. 109, 4275-4280
39. Balla, T. (2013) Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol. Rev. 93, 1019-1137
40. Stahelin, R. V., Scott, J. L., and Frick, C. T. (2014) Cellular and molecular interactions of phosphoinositides and peripheral proteins. Chem. Phys. Lipids 182, 3-18
41. Moravcevic, K., Oxley, C. L., and Lemmon, M. A. (2012) Conditional peripheral membrane proteins: facing up to limited specificity. Structure 20, 15-27
42. van Meer, G., Voelker, D. R., and Feigenson, G. W. (2008) Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112-124
43. Vance, J. E., and Steenbergen, R. (2005) Metabolism and functions of phosphatidylserine. Prog. Lipid Res. 44, 207-234
44. Vance, J. E., and Tasseva, G. (2013) Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim. Biophys. Acta 1831, 543-554
45. Cho, W., and Stahelin, R. V. (2006) Membrane binding and subcellular targeting of C2 domains. Biochim. Biophys. Acta 1761, 838-849
46. Dick, R. A., Goh, S. L., Feigenson, G. W., and Vogt, V. M. (2012) HIV-1 Gag protein can sense the cholesterol and acyl chain environment in model membranes. Proc. Natl. Acad. Sci. U.S.A. 109, 18761-18766
47. Zakowski, J. J., Petri, W. A., Jr., and Wagner, R. R. (1981) Role of matrix protein in assembling the membrane of vesicular stomatitis virus: reconstitution of matrix protein with negatively charged phospholipid vesicles. Biochemistry 20, 3902-3907
48. Scianimanico, S., Schoehn, G., Timmins, J., Ruigrok, R. H., Klenk, H. D., and Weissenhorn, W. (2000) Membrane association induces a conformational change in the Ebola virus matrix protein. EMBO J. 19, 6732-6741
49. Fairn, G. D., Schieber, N. L., Ariotti, N., Murphy, S., Kuerschner, L., Webb, R. I., Grinstein, S., and Parton, R. G. (2011) High-resolution mapping reveals topologically distinct cellular pools of phosphatidylserine. J. Cell Biol. 194, 257-275
50. García, M., Cooper, A., Shi, W., Bornmann, W., Carrion, R., Kalman, D., and Nabel, G. J. (2012) Productive replication of Ebola virus Is regulated by the c-Abl1 tyrosine kinase. Sci. Transl. Med. 4, 123ra124
51. Helfrich, W. (1973) Elastic properties of lipid bilayers: theory and possible experiments. Z. Naturforsch. C 28, 693-703